太龙药业：2025年第三季度归属于上市公司股东的净利润同比增长162.48%

Group 1 - The core point of the article is that Tai Long Pharmaceutical reported its Q3 2025 financial results, showing a revenue increase and a significant rise in net profit [1] Group 2 - In Q3 2025, the company achieved a revenue of 424,470,623.44 yuan, representing a year-on-year growth of 2.67% [1] - The net profit attributable to shareholders of the listed company was 5,978,861.00 yuan, reflecting a substantial year-on-year increase of 162.48% [1]